381 reports of this reaction
3.7% of all VARENICLINE reports
#4 most reported adverse reaction
VOMITING is the #4 most commonly reported adverse reaction for VARENICLINE, manufactured by Oyster Point Pharma, Inc.. There are 381 FDA adverse event reports linking VARENICLINE to VOMITING. This represents approximately 3.7% of all 10,186 adverse event reports for this drug.
Patients taking VARENICLINE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is moderately reported among VARENICLINE users, representing a notable but not dominant share of adverse events.
In addition to vomiting, the following adverse reactions have been reported for VARENICLINE:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 381 FDA reports for VARENICLINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 3.7% of all adverse event reports for VARENICLINE, making it a notable side effect.
If you experience vomiting while taking VARENICLINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.